Status
Conditions
Treatments
About
In this proposed human trial, the investigators aim to establish whether 4 weeks of daily consumption of beta-glucan matched meals providing either a high dose or a moderate dose of oat avenanthramides and phenolic acids leads to dose-dependent chronic improvements in markers of CVD risk and gut health relative to an energy matched control intervention in healthy adults with above average blood pressure.
Full description
To explore correlations between bacterial population changes and CVD risk markers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Jeremy P Spencer, Professor; Manuel Y Schar, PDRA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal